{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:36:27Z","timestamp":1790847387293,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/pr.2016.247","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T17:02:16Z","timestamp":1479402136000},"page":"406-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Advances in the care of children with lupus nephritis"],"prefix":"10.1038","volume":"81","author":[{"given":"Scott E.","family":"Wenderfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"key":"BFpr2016247_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/acr.21757","volume":"64","author":"CA Silva","year":"2012","unstructured":"Silva CA, Avcin T, Brunner HI. Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res (Hoboken) 2012;64:1787\u201393.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1177\/0961203311416694","volume":"20","author":"B Livingston","year":"2011","unstructured":"Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 2011;20:1345\u201355.","journal-title":"Lupus"},{"key":"BFpr2016247_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/art.34472","volume":"64","author":"LT Hiraki","year":"2012","unstructured":"Hiraki LT, Feldman CH, Liu J, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 2012;64:2669\u201376.","journal-title":"Arthritis Rheum"},{"issue":"14","key":"BFpr2016247_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA. Differences in disease phenotype and severity in SLE across age groups. Lupus 2016;25 (14):1542\u201350.","journal-title":"Lupus"},{"key":"BFpr2016247_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/art.23204","volume":"58","author":"HI Brunner","year":"2008","unstructured":"Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008;58:556\u201362.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1542\/peds.40.5.822","volume":"40","author":"WW Hagge","year":"1967","unstructured":"Hagge WW, Burke EC, Stickler GB. Treatment of systemic lupus erythematosus complicated by nephritis in children. Pediatrics 1967;40:822\u20137.","journal-title":"Pediatrics"},{"key":"BFpr2016247_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1542\/peds.42.1.37","volume":"42","author":"AG Meislin","year":"1968","unstructured":"Meislin AG, Rothfield N. Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 1968;42:37\u201349.","journal-title":"Pediatrics"},{"key":"BFpr2016247_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.40.4.325","volume":"40","author":"F Caeiro","year":"1981","unstructured":"Caeiro F, Michielson FM, Bernstein R, Hughes GR, Ansell BM. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981;40:325\u201331.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2016247_CR9","first-page":"234","volume":"24","author":"MM Hargraves","year":"1949","unstructured":"Hargraves MM. Production in vitro of the L.E. cell phenomenon; use of normal bone marrow elements and blood plasma from patients with acute disseminated lupus erythematosus. Proc Staff Meet Mayo Clin 1949;24:234\u20137.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"BFpr2016247_CR10","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0961203314563817","volume":"24","author":"T Tarr","year":"2015","unstructured":"Tarr T, D\u00e9rfalvi B, Gy\u0151ri N, et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus 2015;24:796\u2013803.","journal-title":"Lupus"},{"key":"BFpr2016247_CR12","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677\u201386.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR13","first-page":"440","volume":"32","author":"E Sag","year":"2014","unstructured":"Sag E, Tartaglione A, Batu ED, et al. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol 2014;32:440\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"BFpr2016247_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/rheumatology\/keu278","volume":"54","author":"AR Fonseca","year":"2015","unstructured":"Fonseca AR, Gaspar-Elsas MI, Land MG, de Oliveira SK. Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology (Oxford) 2015;54:241\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"BFpr2016247_CR15","first-page":"41","volume":"19","author":"MD Sinha","year":"2006","unstructured":"Sinha MD, Lewis MA, Bradbury MG, Webb NJ. Percutaneous real-time ultrasound-guided renal biopsy by automated biopsy gun in children: safety and complications. J Nephrol 2006;19:41\u20134.","journal-title":"J Nephrol"},{"key":"BFpr2016247_CR16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2215\/CJN.02150212","volume":"7","author":"C T\u00f8ndel","year":"2012","unstructured":"T\u00f8ndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. Clin J Am Soc Nephrol 2012;7:1591\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFpr2016247_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"BFpr2016247_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000167563","volume":"8","author":"HL Corwin","year":"1988","unstructured":"Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988;8:85\u20139.","journal-title":"Am J Nephrol"},{"key":"BFpr2016247_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/0961203314531841","volume":"23","author":"A Boneparth","year":"2014","unstructured":"Boneparth A, Ilowite NT ; CARRA Registry Investigators. Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry. Lupus 2014;23:898\u2013904.","journal-title":"Lupus"},{"key":"BFpr2016247_CR20","first-page":"2635","volume":"29","author":"S Hagelberg","year":"2002","unstructured":"Hagelberg S, Lee Y, Bargman J, et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002;29:2635\u201342.","journal-title":"J Rheumatol"},{"key":"BFpr2016247_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00467-004-1419-y","volume":"19","author":"M Zappitelli","year":"2004","unstructured":"Zappitelli M, Duffy C, Bernard C, et al. Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol 2004;19:503\u201310.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR22","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00467-015-3138-y","volume":"30","author":"P Rianthavorn","year":"2015","unstructured":"Rianthavorn P, Buddhasri A. Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis. Pediatr Nephrol 2015;30:1969\u201376.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00467-006-0296-y","volume":"22","author":"SD Marks","year":"2007","unstructured":"Marks SD, Sebire NJ, Pilkington C, Tullus K. Clinicopathological correlations of paediatric lupus nephritis. Pediatr Nephrol 2007;22:77\u201383.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","volume":"75","author":"HA Austin 3rd","year":"1983","unstructured":"Austin HA 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983;75:382\u201391.","journal-title":"Am J Med"},{"key":"BFpr2016247_CR25","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1046\/j.1523-1755.2000.00272.x","volume":"58","author":"GS Hill","year":"2000","unstructured":"Hill GS, Delahousse M, Nochy D, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 2000;58:1160\u201373.","journal-title":"Kidney Int"},{"key":"BFpr2016247_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00467-007-0619-7","volume":"23","author":"M Zappitelli","year":"2008","unstructured":"Zappitelli M, Duffy CM, Bernard C, Gupta IR. Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 2008;23:83\u201391.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/acr.22762","volume":"68","author":"HI Brunner","year":"2016","unstructured":"Brunner HI, Bennett MR, Abulaban K, et al. Development of a novel renal activity index of lupus nephritis in children and young adults. Arthritis Care Res (Hoboken) 2016;68:1003\u201311.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12969-015-0024-x","volume":"13","author":"SE Wenderfer","year":"2015","unstructured":"Wenderfer SE, Lane JC, Shatat IF, von Scheven E, Ruth NM. Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance. Pediatr Rheumatol Online J 2015;13:26.","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFpr2016247_CR29","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1002\/art.24751","volume":"60","author":"CH Hinze","year":"2009","unstructured":"Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum 2009;60:2772\u201381.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","volume":"65","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Wiers K, Brooks EB, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009;65:530\u20136.","journal-title":"Pediatr Res"},{"key":"BFpr2016247_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00467-013-2668-4","volume":"29","author":"L Watson","year":"2014","unstructured":"Watson L, Tullus K, Pilkington C, et al. Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol 2014;29:397\u2013405.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","volume":"49","author":"T Rubinstein","year":"2010","unstructured":"Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) 2010;49:960\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"BFpr2016247_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2217\/bmm.15.26","volume":"9","author":"TB Rubinstein","year":"2015","unstructured":"Rubinstein TB, Putterman C, Goilav B. Biomarkers for CNS involvement in pediatric lupus. Biomark Med 2015;9:545\u201358.","journal-title":"Biomark Med"},{"key":"BFpr2016247_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-016-0064-x","volume":"14","author":"KM Abulaban","year":"2016","unstructured":"Abulaban KM, Fall N, Nunna R, et al. Relationship of cell-free urine MicroRNA with lupus nephritis in children. Pediatr Rheumatol Online J 2016;14:4.","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFpr2016247_CR35","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/0961203315570162","volume":"24","author":"SD Sule","year":"2015","unstructured":"Sule SD, Moodalbail DG, Burnham J, Fivush B, Furth SL. Predictors of kidney disease in a cohort of pediatric patients with lupus. Lupus 2015;24:862\u20138.","journal-title":"Lupus"},{"key":"BFpr2016247_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/acr.21558","volume":"64","author":"R Mina","year":"2012","unstructured":"Mina R, von Scheven E, Ardoin SP, et al.; Carra SLE Subcommittee. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012;64:375\u201383.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR37","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/art.10558","volume":"47","author":"AF Kavanaugh","year":"2002","unstructured":"Kavanaugh AF, Solomon DH ; American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002;47:546\u201355.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/keh719","volume":"44","author":"G Sturfelt","year":"2005","unstructured":"Sturfelt G, Truedsson L. Complement and its breakdown products in SLE. Rheumatology (Oxford) 2005;44:1227\u201332.","journal-title":"Rheumatology (Oxford)"},{"key":"BFpr2016247_CR39","first-page":"CD002922","volume":"12","author":"L Henderson","year":"2012","unstructured":"Henderson L, Masson P, Craig JC, et al. Treatment for lupus nephritis. Cochrane Database Syst Rev 2012;12:CD002922.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFpr2016247_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-3476(82)80203-5","volume":"101","author":"KS Barron","year":"1982","unstructured":"Barron KS, Person DA, Brewer EJ Jr, Beale MG, Robson AM. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Pediatr 1982;101:137\u201341.","journal-title":"J Pediatr"},{"key":"BFpr2016247_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0022-3476(00)70109-0","volume":"136","author":"TJ Lehman","year":"2000","unstructured":"Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000;136:243\u20137.","journal-title":"J Pediatr"},{"key":"BFpr2016247_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pedhc.2007.07.006","volume":"22","author":"KK Lau","year":"2008","unstructured":"Lau KK, Ault BH, Jones DP, Butani L. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil. J Pediatr Health Care 2008;22:282\u20138.","journal-title":"J Pediatr Health Care"},{"key":"BFpr2016247_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/03009749709105310","volume":"26","author":"ED Silverman","year":"1997","unstructured":"Silverman ED, Lang B. An overview of the treatment of childhood SLE. Scand J Rheumatol 1997;26:241\u20136.","journal-title":"Scand J Rheumatol"},{"key":"BFpr2016247_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.2008.102533","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010;69:61\u20134.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2016247_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0961203308094999","volume":"18","author":"F Falcini","year":"2009","unstructured":"Falcini F, Capannini S, Martini G, et al. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus 2009;18:139\u201343.","journal-title":"Lupus"},{"key":"BFpr2016247_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/14397595.2014.950810","volume":"25","author":"T Kizawa","year":"2015","unstructured":"Kizawa T, Nozawa T, Kikuchi M, et al. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis. Mod Rheumatol 2015;25:210\u20134.","journal-title":"Mod Rheumatol"},{"key":"BFpr2016247_CR47","first-page":"2103","volume":"28","author":"S Buratti","year":"2001","unstructured":"Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001;28:2103\u20138.","journal-title":"J Rheumatol"},{"key":"BFpr2016247_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2014-206897","volume":"75","author":"F Tamirou","year":"2016","unstructured":"Tamirou F, D\u2019Cruz D, Sangle S, et al.; MAINTAIN Nephritis Trial Group. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis 2016;75:526\u201331.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2016247_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.ajkd.2010.08.036","volume":"57","author":"W Chen","year":"2011","unstructured":"Chen W, Tang X, Liu Q, et al. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial. Am J Kidney Dis 2011;57:235\u201344.","journal-title":"Am J Kidney Dis"},{"key":"BFpr2016247_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/rheumatology\/37.2.217","volume":"37","author":"LW Fu","year":"1998","unstructured":"Fu LW, Yang LY, Chen WP, Lin CY. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 1998;37:217\u201321.","journal-title":"Br J Rheumatol"},{"key":"BFpr2016247_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0961203315615220","volume":"25","author":"E Aragon","year":"2016","unstructured":"Aragon E, Resontoc LP, Chan YH, et al. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus 2016;25:399\u2013406.","journal-title":"Lupus"},{"key":"BFpr2016247_CR52","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.2215\/CJN.00910111","volume":"6","author":"T Pereira","year":"2011","unstructured":"Pereira T, Abitbol CL, Seeherunvong W, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol 2011;6:2192\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFpr2016247_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2006.01.041","volume":"148","author":"M Willems","year":"2006","unstructured":"Willems M, Haddad E, Niaudet P, et al.; French Pediatric-Onset SLE Study Group. Rituximab therapy for childhood-onset systemic lupus erythematosus. J Pediatr 2006;148:623\u20137.","journal-title":"J Pediatr"},{"key":"BFpr2016247_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1546-0096-12-3","volume":"12","author":"TJ Lehman","year":"2014","unstructured":"Lehman TJ, Singh C, Ramanathan A, et al. Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide. Pediatr Rheumatol Online J 2014;12:3.","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFpr2016247_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0961203314547793","volume":"24","author":"L Watson","year":"2015","unstructured":"Watson L, Beresford MW, Maynes C, et al. The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. Lupus 2015;24:10\u20137.","journal-title":"Lupus"},{"key":"BFpr2016247_CR56","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3899\/jrheum.140863","volume":"42","author":"A Tambralli","year":"2015","unstructured":"Tambralli A, Beukelman T, Cron RQ, Stoll ML. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. J Rheumatol 2015;42:541\u20136.","journal-title":"J Rheumatol"},{"key":"BFpr2016247_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363\u20139.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR58","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/art.10072","volume":"46","author":"HI Brunner","year":"2002","unstructured":"Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436\u201344.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR59","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1177\/0961203315599449","volume":"24","author":"JO Sato","year":"2015","unstructured":"Sato JO, Corrente JE, Saad-Magalh\u00e3es C. Chronic active disease pattern predicts early damage in juvenile systemic lupus erythematosus. Lupus 2015;24:1421\u20138.","journal-title":"Lupus"},{"key":"BFpr2016247_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/annrheumdis-2012-202376","volume":"73","author":"R Mina","year":"2014","unstructured":"Mina R, Klein-Gitelman MS, Nelson S, et al. Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus. Ann Rheum Dis 2014;73:401\u20136.","journal-title":"Ann Rheum Dis"},{"key":"BFpr2016247_CR61","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/acr.22363","volume":"66","author":"DM Levy","year":"2014","unstructured":"Levy DM, Peschken CA, Tucker LB, et al. Health related quality of life in childhood-onset systemic lupus erythematosus is associated with ethnicity: Results from a multiethnic multicenter Canadian cohort. Arthritis Care Res 2014;66:1767\u201374.","journal-title":"Arthritis Care Res"},{"key":"BFpr2016247_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/art.30645","volume":"64","author":"LE Schanberg","year":"2012","unstructured":"Schanberg LE, Sandborg C, Barnhart HX, et al.; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum 2012;64:285\u201396.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/intqhc\/13.6.469","volume":"13","author":"HR Rubin","year":"2001","unstructured":"Rubin HR, Pronovost P, Diette GB. The advantages and disadvantages of process-based measures of health care quality. Int J Qual Health Care 2001;13:469\u201374.","journal-title":"Int J Qual Health Care"},{"key":"BFpr2016247_CR64","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/acr.21998","volume":"65","author":"MC Hollander","year":"2013","unstructured":"Hollander MC, Sage JM, Greenler AJ, et al. International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013;65:1416\u201323.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/acr.22666","volume":"68","author":"R Mina","year":"2016","unstructured":"Mina R, Harris JG, Klein-Gitelman MS, et al. Initial benchmarking of the quality of medical care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2016;68:179\u201386.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR66","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/acr.22749","volume":"68","author":"DJ Tunnicliffe","year":"2016","unstructured":"Tunnicliffe DJ, Singh-Grewal D, Chaitow J, et al. Lupus means sacrifices: perspectives of adolescents and young adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2016;68:828\u201337.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR67","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/acr.20507","volume":"63","author":"HI Brunner","year":"2011","unstructured":"Brunner HI, Mina R, Pilkington C, et al. Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:1213\u201323.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR68","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/acr.22611","volume":"67","author":"S Felsenstein","year":"2015","unstructured":"Felsenstein S, Reiff AO, Ramanathan A. Transition of care and health-related outcomes in pediatric-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2015;67:1521\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR69","unstructured":"KDIGOcommunications. KDIGO Clinical Practice Guideline for Glomerulonephritis, 2012. http:\/\/kdigo.org\/home\/glomerulonephritis-gn\/."},{"key":"BFpr2016247_CR70","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/ndt\/gfs589","volume":"28","author":"B Ruggiero","year":"2013","unstructured":"Ruggiero B, Vivarelli M, Gianviti A, et al. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study. Nephrol Dial Transplant 2013;28:1487\u201396.","journal-title":"Nephrol Dial Transplant"},{"key":"BFpr2016247_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/acr.21779","volume":"65","author":"DM Levy","year":"2012","unstructured":"Levy DM, Peschken CA, Tucker LB, et al. The 1000 Canadian faces of lupus: Influence of ethnicity on disease in the pediatric cohort. Arthritis Care Res 2012;65:152\u201360.","journal-title":"Arthritis Care Res"},{"key":"BFpr2016247_CR72","doi-asserted-by":"crossref","unstructured":"Lewandowski LB, Schanberg LE, Thielman N, et al. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lupus 2016; e-pub ahead of print 3 August 2016.","DOI":"10.1177\/0961203316660625"},{"key":"BFpr2016247_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0961203306075385","volume":"16","author":"Y Uziel","year":"2007","unstructured":"Uziel Y, Gorodnitski N, Mukamel M, et al.; Pediatric Rheumatology Study Group Of Israel @ SLERI. Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus 2007;16:142\u20136.","journal-title":"Lupus"},{"key":"BFpr2016247_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0002-9343(77)90355-2","volume":"62","author":"AJ Fish","year":"1977","unstructured":"Fish AJ, Blau EB, Westberg NG, Burke BA, Vernier RL, Michael AF. Systemic lupus erythematosus within the first two decades of life. Am J Med 1977;62:99\u2013117.","journal-title":"Am J Med"},{"key":"BFpr2016247_CR75","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1542\/peds.89.2.240","volume":"89","author":"DK McCurdy","year":"1992","unstructured":"McCurdy DK, Lehman TJ, Bernstein B, et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992;89:240\u20136.","journal-title":"Pediatrics"},{"key":"BFpr2016247_CR76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0090-1229(83)90024-7","volume":"29","author":"RS Glidden","year":"1983","unstructured":"Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 1983;29:196\u2013210.","journal-title":"Clin Immunol Immunopathol"},{"key":"BFpr2016247_CR77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s004670200008","volume":"17","author":"S Vyas","year":"2002","unstructured":"Vyas S, Hidalgo G, Baqi N, Von Gizyki H, Singh A. Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatr Nephrol 2002;17:45\u20139.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR78","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1681\/ASN.V76924","volume":"7","author":"N Baqi","year":"1996","unstructured":"Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996;7:924\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"BFpr2016247_CR79","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00467-003-1278-y","volume":"19","author":"R Bogdanovi\u0107","year":"2004","unstructured":"Bogdanovi\u0107 R, Nikoli\u0107 V, Pasi\u0107 S, et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 2004;19:36\u201344.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR80","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/adc.2010.183699","volume":"96","author":"P Vachvanichsanong","year":"2011","unstructured":"Vachvanichsanong P, Dissaneewate P, McNeil E. Twenty-two years\u2019 experience with childhood-onset SLE in a developing country: are outcomes similar to developed countries? Arch Dis Child 2011;96:44\u20139.","journal-title":"Arch Dis Child"},{"key":"BFpr2016247_CR81","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0961203314563133","volume":"24","author":"D Batini\u0107","year":"2015","unstructured":"Batini\u0107 D, Milo\u0161evi\u0107 D, \u010cori\u0107 M, Topalovi\u0107-Grkovi\u0107 M, Jelu\u0161i\u0107 M, Turudi\u0107 D. Lupus nephritis in Croatian children: clinicopathologic findings and outcome. Lupus 2015;24:307\u201314.","journal-title":"Lupus"},{"key":"BFpr2016247_CR82","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/acr.20179","volume":"62","author":"AO Hersh","year":"2010","unstructured":"Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62:1152\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFpr2016247_CR83","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/art.39594","volume":"68","author":"MG Tektonidou","year":"2016","unstructured":"Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and bayesian meta-analysis. Arthritis Rheumatol 2016;68:1432\u201341.","journal-title":"Arthritis Rheumatol"},{"key":"BFpr2016247_CR84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2013.07.005","volume":"43","author":"JY Wu","year":"2014","unstructured":"Wu JY, Yeh KW, Huang JL. Early predictors of outcomes in pediatric lupus nephritis: focus on proliferative lesions. Semin Arthritis Rheum 2014;43:513\u201320.","journal-title":"Semin Arthritis Rheum"},{"key":"BFpr2016247_CR85","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0961203315570166","volume":"24","author":"S Singh","year":"2015","unstructured":"Singh S, Abujam B, Gupta A, et al. Childhood lupus nephritis in a developing country-24 years\u2019 single-center experience from North India. Lupus 2015;24:641\u20137.","journal-title":"Lupus"},{"key":"BFpr2016247_CR86","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00467-007-0447-9","volume":"22","author":"D Askenazi","year":"2007","unstructured":"Askenazi D, Myones B, Kamdar A, et al. Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy. Pediatr Nephrol 2007;22:981\u20136.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00467-006-0286-0","volume":"22","author":"BS Lee","year":"2007","unstructured":"Lee BS, Cho HY, Kim EJ, et al. Clinical outcomes of childhood lupus nephritis: a single center\u2019s experience. Pediatr Nephrol 2007;22:222\u201331.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR88","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00467-006-0129-z","volume":"21","author":"S Nathanson","year":"2006","unstructured":"Nathanson S, Salomon R, Ranchin B, et al. Prognosis of lupus membranous nephropathy in children. Pediatr Nephrol 2006;21:1113\u20136.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR89","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00467-014-2908-2","volume":"30","author":"B Hugle","year":"2015","unstructured":"Hugle B, Silverman ED, Tyrrell PN, Harvey EA, H\u00e9bert D, Benseler SM. Presentation and outcome of paediatric membranous non-proliferative lupus nephritis. Pediatr Nephrol 2015;30:113\u201321.","journal-title":"Pediatr Nephrol"},{"key":"BFpr2016247_CR90","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/art.30350","volume":"63","author":"LT Hiraki","year":"2011","unstructured":"Hiraki LT, Lu B, Alexander SR, et al. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum 2011;63:1988\u201397.","journal-title":"Arthritis Rheum"},{"key":"BFpr2016247_CR91","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/00007890-200109150-00047","volume":"72","author":"SM Bartosh","year":"2001","unstructured":"Bartosh SM, Fine RN, Sullivan EK. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study. Transplantation 2001;72:973\u20138.","journal-title":"Transplantation"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pr2016247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pr2016247","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pr2016247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T20:09:40Z","timestamp":1650398980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFpr2016247"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.247","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]},"assertion":[{"value":"4 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}